Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Luis Miranda Torres

Orthopaedic Surgery Caguas, PR Medical Doctor

NPI 1437268083 CMS profile 156414

201 Calle Gautier Benitez, Consolidated Medical Plaza, Ste.305, Caguas, PR 00725

Open in the dashboard

General payments

$10,618

89 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Luis Miranda Torres of Caguas, PR is reported in the CMS Open Payments database as having received $10,618 across 89 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 71st percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $85 1
2024 General $1,424 19
2023 General $1,952 21
2022 General $341 1
2021 General $1,316 8
2020 General $1,981 17
2019 General $3,520 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Luis Miranda Torres
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Luis Miranda Torres were reported at $85. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Luis Miranda Torres Orthopaedic Surgery median Middle half National median
2019 $3,520 $644 $140–$2,844 $163
2020 $1,981 $312 $75–$1,860 $114
2021 $1,316 $520 $117–$2,495 $132
2022 $341 $598 $128–$2,731 $149
2023 $1,952 $461 $128–$2,264 $160
2024 $1,424 $497 $134–$2,475 $164
2025 $85 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $9,267 78 payments
  2. Encore Medical, LP $1,044 5 payments
  3. RMC Orthopedic & Surgical, Inc. $244 3 payments
  4. Johnson and Johnson International $44 2 payments
  5. Ferring Pharmaceuticals Inc. $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $5,895 25 payments
  2. Food and Beverage $2,017 61 payments
  3. Education $1,956 2 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $750 1 payment
Products named General payments · program years 2019–2025
  1. DJO Surgical Empowr Knee System $906 2 payments
  2. DJO Surgical 3DKnee System $138 3 payments
  3. ARTHREX Knee $105 1 payment
  4. ARTHREX Shoulder $54 1 payment
  5. ATTUNE $44 2 payments
  6. HEALIX KNOTLESS PEEK $33 1 payment
  7. EUFLEXXA $18 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

529

Median for Orthopedic Surgery: 203

Drug cost

$5,309

Median for Orthopedic Surgery: $1,433

Branded share of claims

30.6%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Potassium Generic 45 $1,246
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 104 $1,144
Acetaminophen-Codeine Acetaminophen With Codeine Brand 58 $1,115
Meloxicam Generic 95 $588
Tizanidine Hcl Generic 94 $445
Cephalexin Generic 52 $288
Gabapentin Generic 47 $240
Sulindac Generic 14 $128
Tramadol Hcl Generic 20 $114

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 21 billing codes

Paid by Medicare

$17,003

Of which drugs: $118

Medicare patients

32

Average age 73

Services billed

182

18 women, 14 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 66%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 11 22 $118

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

89 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Puerto Rico

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record